XML 29 R31.htm IDEA: XBRL DOCUMENT v3.3.0.814
Segment Reporting (Tables)
9 Months Ended
Sep. 30, 2015
Segment Reporting [Abstract]  
Reconciliation of the Company's business segments to the consolidated financial statements
In millions
Pharmacy
Services
Segment(1)
 
Retail/LTC
Segment
 
Corporate
Segment
 
Intersegment
Eliminations(2)
 
Consolidated
Totals
Three Months Ended
 
 
 
 
 
 
 
 
 
September 30, 2015:
 
 
 
 
 
 
 
 
 
Net revenues
$
25,528

 
$
17,912

 
$

 
$
(4,796
)
 
$
38,644

Gross profit
1,468

 
5,373

 

 
(180
)
 
6,661

Operating profit (loss)(3)
1,162

 
1,643

 
(309
)
 
(165
)
 
2,331

September 30, 2014:
 

 
 

 
 

 
 

 
 

Net revenues
22,534

 
16,749

 

 
(4,262
)
 
35,021

Gross profit
1,403

 
5,237

 

 
(172
)
 
6,468

Operating profit (loss)
1,087

 
1,527

 
(196
)
 
(172
)
 
2,246

Nine Months Ended
 

 
 

 
 

 
 

 
 

September 30, 2015:
 

 
 

 
 

 
 

 
 

Net revenues
73,849

 
52,105

 

 
(13,810
)
 
112,144

Gross profit
3,735

 
15,990

 

 
(498
)
 
19,227

Operating profit (loss)(3)
2,837

 
5,050

 
(712
)
 
(450
)
 
6,725

September 30, 2014:
 

 
 

 
 

 
 

 
 

Net revenues
64,566

 
50,100

 

 
(12,354
)
 
102,312

Gross profit
3,533

 
15,719

 

 
(518
)
 
18,734

Operating profit (loss)
2,605

 
4,982

 
(591
)
 
(518
)
 
6,478


(1)          Net revenues of the Pharmacy Services Segment include approximately $2.1 billion and $1.9 billion of retail co-payments for the three months ended September 30, 2015 and 2014, respectively, as well as $6.8 billion and $6.1 billion of retail co-payments for the nine months ended September 30, 2015 and 2014, respectively.
(2)      Intersegment eliminations relate to intersegment revenue generating activities that occur between the Pharmacy Services Segment and the Retail/LTC Segment. These occur in the following ways: when members of Pharmacy Services Segment clients (“members”) fill prescriptions at retail stores to purchase covered products, when members enrolled in programs such as Maintenance Choice® elect to pick up maintenance prescriptions at a retail drugstore instead of receiving them through the mail, or when members have prescriptions filled at long-term care facilities. When these occur, both the Pharmacy Services and Retail/LTC segments record the revenues, gross profit and operating profit on a standalone basis.
(3)
The Corporate Segment operating loss includes $115 million and $135 million of acquisition-related transaction and integration costs for the three and nine months ended September 30, 2015, respectively.